Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Glenn Baity


  • Evp And Gc at Acadia Pharmaceuticals Inc (ACAD), 2018-04-20
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
ACAD $32.39 36,558 83,734 2018-01-29 Filing
ACAD $30.14 74,321 70,113 2018-01-02 Filing
ACAD $40.91 37,500 69,656 2017-10-05 Filing
ACAD $34.87 26,507 67,656 2017-08-30 Filing
ACAD $34.88 14,322 77,656 2017-08-09 Filing